Life Sciences

Members Only

India's pharmaceutical industry is the fourth largest in the world. This sector is poised for spectacular growth and international participation if a proper policy environment in India can be established and maintained.

Indian companies are proving their credentials, establishing presence in the United States and throughout the world. Cooperation between the U.S. and Indian life sciences industries requires the development of a proper policy environment that will enhance business opportunities in both
countries.

USIBC's Executive Committee on Life Sciences focuses on several objectives that are outlined below:

• Advocate the formulation and implementation of a world class vaccines program that encourages private sector involvement
• Advocate for the adoption of data exclusivity in accordance with India's Trade-Related Aspects of Intellectual Property Rights (TRIPS) obligations under Article 39.3 to protect undisclosed test data from unfair commercial use
• Work with counterpart organizations in India to gain assurances that the scope of patent protection will not be impermissibly limited to new chemical entities and that incremental innovation will be protected
• Advocate against price controls to ensure that any pricing regime is developed in consultation with industry in order to strike the correct balance between the need for access and the need to foster innovation
• Fight against pharmaceutical counterfeiting in India
• Launch a Life Sciences Executive Mission to India to showcase India's emergence as a major R&D Center